FIELD: medicine.
SUBSTANCE: combination therapy for chronic limb ischemia is ensured by revascularisation osteomyoplasty performed on the laboratory animal with experimental limb on 7th day after modelling. It is followed with intraperitoneal introduction of L-arginine once a day assuring effective circulation management.
EFFECT: higher clinical effectiveness.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PHARMACOLOGICAL CORRECTION OF LIMB'S ISCHEMIA | 2006 |
|
RU2302239C1 |
METHOD OF TREATING CHRONIC LIMB ISCHEMIA EXPERIMENTALLY | 2014 |
|
RU2556606C1 |
METHOD FOR PHARMACOLOGICAL STIMULATION OF NEOANGIOGENESIS IN TREATING ACUTE EXPERIMENTAL LIMB ISCHEMIA | 2014 |
|
RU2559937C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF EXTREMITY ISCHEMIA INCLUDING IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2010 |
|
RU2426174C1 |
ISCHEMIA CORRECTION METHOD | 2010 |
|
RU2438192C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXTREMITY ISCHEMIA | 2011 |
|
RU2466463C2 |
METHOD OF PHARMACOLOGICAL CORRECTION OF EXTREMITY ISCHEMIA BY MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS | 2011 |
|
RU2455025C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH SIMVASTATIN | 2020 |
|
RU2726076C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW | 2020 |
|
RU2735838C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND UDENAFIL | 2020 |
|
RU2727891C1 |
Authors
Dates
2009-04-27—Published
2007-12-06—Filed